Novartis

The more researchers know about how different therapies work and for whom they work, the faster they can make progress in finding treatments, said Dr. William Nelson, director of Johns Hopkins Kimmel Cancer Center during a panel discussion on March 8 about precision medicine moderated by The Washington Post’s Laurie McGinley. The discussion was part of Johns Hopkins Medicine’s On the Road to Precision Medicine Health Care Leader Series , which explores topics of cost, communication, research, and health care delivery in relation to precision medicine. Regarding concerns that the drug approval process is too lengthy, Nelson said that the efficiency achieved by focusing on creating targeted...
A lab-turned-hospital for mice in Boston is helping researchers understand cancer in humans. Jessica Rinaldi for The New York Times Maybe this sounds like the opening line to one of those wasteful-spending reports, but it’€™s not. And the results ’€” while still a long way from producing a treatment ’€” have allowed researchers to gain insight into the links between cancer and a handful of mutated genes. New York Times reporter Gina Kolkata describes the ’€œhospital’€ at Beth Israel Deaconess Medical Center: imaging devices writ small with a dedicated pharmacy and clinical lab. She follows researchers that are looking into prostate cancer. Mice are injected with a few rogue genes, and...

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient